Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Medicina (Kaunas) ; 60(3)2024 Feb 22.
Article En | MEDLINE | ID: mdl-38541097

Keratoacanthoma (KA) is a fast-growing skin tumor subtype that can be observed as a solitary lesion or rarely as multiple lesions in the context of rare genetic syndromes. Syndromes with multiple keratoacanthoma-like lesions have been documented as multiple self-healing squamous epithelioma (Ferguson-Smith syndrome), eruptive keratoacanthoma of Grzybowski, multiple familial keratoacanthoma of Witten and Zak Muir-Torre syndrome, and incontinentia pigmenti. The treatment approach of those entities is challenging due to the numerous lesions, the lesions' undefined nature, and the co-existence of other malignant skin tumors. Herein, we report a case of a 40-year-old woman who developed multiple treatment-resistant Ferguson-Smith-like keratoacanthomas with a co-existing large and ulcerated invasive squamous cell carcinoma and microcystic adnexal carcinoma on the scalp. Multiple keratoacanthomas on her extremities were successfully treated with oral acitretin (0.5 mg/kg/day) in combination with topical Fluorouracil (5-FU) 5%, while excision and plastic surgery restoration were performed to treat the ulcerated cancer lesion on her scalp. Due to the interesting nature of this rare syndrome, we performed a literature review including case reports and case series on multiple-KA-like lesions syndromes and focusing on diagnosis and therapy approaches. We also conducted a comparison of patient reports, which included assessing the clinical appearance of the lesions and evaluating the success and progress or the failure of various treatment approaches that were implemented.


Carcinoma, Squamous Cell , Keratoacanthoma , Skin Neoplasms , Humans , Female , Adult , Keratoacanthoma/diagnosis , Keratoacanthoma/drug therapy , Keratoacanthoma/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/drug therapy , Carcinoma, Squamous Cell/diagnosis , Acitretin/therapeutic use , Fluorouracil/therapeutic use
2.
Adv Exp Med Biol ; 1424: 265-272, 2023.
Article En | MEDLINE | ID: mdl-37486503

BACKGROUND: Primary care serves as the first point of contact for people with dementia and is therefore a promising setting for screening, assessment, and initiation of specific treatment and care. According to literature, online applications can be effective by addressing different needs, such as screening, health counseling, and improving overall health status. AIM: Our goal was to propose a brief, inexpensive, noninvasive strategy for screening dementia to general, multicultural population and persons with disabilities, through a web-based app with a tailored multicomponent design. METHODS: We designed and developed a web-based application, which combines cognitive tests and biomarkers to assist primary care professionals screen dementia. We then conducted an implementation study to measure the usability of the app. Two groups of experts participated for the selection of the screening instruments, following the Delhi method. Then, 16 primary care professionals assessed the app to their patients (n = 132), and after they measured its usability with System Usability Scale. OUTCOMES: Two cognitive tools were integrated in the app, GPCOG and RUDAS, which are adequate for primary care settings and for screening multicultural and special needs population, without educational or language bias. Also, for assessing biomarkers, the CAIDE model was preferred, which resulted in individualized proposals, concerning the modifiable risk factors. Usability scored high for the majority of users. CONCLUSION: Utilization of the Dementia app could be incorporated into the routine practices of existing healthcare services and screening of multiple population for dementia.


Dementia , Disabled Persons , Mobile Applications , Humans , Dementia/diagnosis , Dementia/epidemiology , Primary Health Care , Patient-Centered Care , Internet
...